Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. 11 Απρ 2023 · Given that D 2 receptor antagonists can worsen catatonia and trigger NMS in an at-risk group, some reviews have urged caution, especially in malignant catatonia (Edinoff et al., 2021; Sienaert et al., 2014; Van den Eede et al., 2005).

    • Login

      Given that D 2 receptor antagonists can worsen catatonia and...

  2. 30 Ιαν 2017 · Malignant catatonia (MC) is a life-threatening manifestation which can occur in the setting of an underlying neuropsychiatric syndrome or general medical illness and shares clinical and pathophysiological features and medical comorbidities with the Neuroleptic Malignant Syndrome (NMS).

  3. 21 Ιουν 2021 · The clinical presentations of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) are similar, posing a diagnostic challenge. Here, we present a 58-year-old Caucasian male who presented to the emergency department with an altered mental state, fever, tachycardia, and rigidity.

  4. 19 Μαΐ 2021 · From a clinical point of view the differential diagnosis of NMS vs. pernicious or malignant catatonia is often a challenge due to similar symptoms.

  5. 25 Σεπ 2024 · Features such as stereotypy, cataplexy, and mannerisms help differentiate catatonia from neuroleptic malignant syndrome.

  6. 11 Αυγ 2020 · Attempts to reconcile the differences have been made by suggesting that NMS and catatonia may represent different presentations of the same illness or that they lie within the same spectrum of a poorly understood clinical syndrome.

  7. 1 Ιουλ 2014 · Abstract. Catatonia is a syndrome, comprised of symptoms such as motor immobility, excessive motor activity, extreme negativism, and stereotyped movements. Neuroleptic is able to induce...

  1. Γίνεται επίσης αναζήτηση για